Development of an intein-mediated split-Cas9 system for gene therapy.
Truong DJ, Kühner K, Kühn R, Werfel S, Engelhardt S, Wurst W, Ortiz O. · 2015
Read Development of an intein-mediated split-Cas9 system for gene therapy. by Truong DJ, Kühner K, Kühn R, Werfel S, Engelhardt S, Wurst W, Ortiz O. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4513872.txt.
Description
Dong-Jiunn Jeffery Truong and six co-authors built a split version of the Cas9 gene-editing tool, reported in Nucleic Acids Research in 2015. Cas9 can be aimed at nearly any gene, but its gene is over 4 kilobases long. That size blocks delivery by the small viruses favored for gene therapy.
Each half of Cas9 was fused to half of an intein, a protein piece that splices itself out. When both halves meet in a cell, the inteins join them and rebuild working Cas9. The rejoined tool cut genes as well as normal Cas9 in reporter and cell tests, across three target genes. A nicking variant also worked, and the pair raised the rate of precise repair. Packed into therapy viruses, the split tool still rebuilt and cut.
Catalog record
| CREATOR | Truong DJ, Kühner K, Kühn R, Werfel S, Engelhardt S, Wurst W, Ortiz O. |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |